Search

Your search keyword '"Demicco M"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Demicco M" Remove constraint Author: "Demicco M"
29 results on '"Demicco M"'

Search Results

2. Liraglutide and Renal Outcomes in Type 2 Diabetes

7. A randomized, placebo‐controlled study of theNS5B inhibitor beclabuvir with peginterferon/ribavirin forHCVgenotype 1

9. 847 ACH-2684 DEMONSTRATES POTENT VIRAL SUPPRESSION IN GENOTYPE 1 HEPATITIS C PATIENTS WITH AND WITHOUT CIRRHOSIS: SAFETY, PHARMACOKINETIC, AND VIRAL KINETIC ANALYSIS

11. 1120 PSI-7977 400 MG QD SAFETY AND TOLERABILITY IN THE FIRST 450 PATIENTS TREATED FOR 12 WEEKS

12. 1163 A PHASE 2A STUDY OF BMS-791325, AN NS5B POLYMERASE INHIBITOR, WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION

13. 1 ATOMIC: 97% RVR FOR PSI-7977 + PEG/RBV × 12 WEEK REGIMEN IN HCV GT1: AN END TO RESPONSE-GUIDED THERAPY?

14. 1219 THREE-DAY, DOSE-RANGING STUDY OF THE HCV NS5A INHIBITOR GS-5885

15. 1372 ONCE DAILY PSI-7977 PLUS PEG-IFN/RBV IN HCV GT1: 98% RAPID VIROLOGIC RESPONSE, COMPLETE EARLY VIROLOGIC RESPONSE: THE PROTON STUDY

19. Metabolic heterogeneity in cancer.

20. A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling.

21. Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasis.

22. PHGDH heterogeneity potentiates cancer cell dissemination and metastasis.

23. Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation.

24. Evaluation of drug-drug interaction between daclatasvir and methadone or buprenorphine/naloxone.

25. Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial.

26. Single- and multiple-ascending-dose studies of the NS3 protease inhibitor asunaprevir in subjects with or without chronic hepatitis C.

27. Residue-free sodium phosphate tablets (OsmoPrep) versus Visicol for colon cleansing: a randomized, investigator-blinded trial.

28. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis.

29. Significance of endoscopically visible blood vessels as an index of atrophic gastritis.

Catalog

Books, media, physical & digital resources